UC2288 is a novel, cell-permeable, orally bioavailable, potent and selective active p21 attenuator. UC2288 inhibits cell growth in the kidney cancer cell lines (GI50 = approximately 10 μM) as well as multiple other cancer cell lines. This novel p21 inhibitor will be indispensable for exploring the function of p21, and upon further study may be translatable to the clinic.

纯度：≥98%

CAS：1394011-91-6